Could flu shot supply fall short this year? FDA's canceled meeting sparks worries
The FDA’s abrupt decision to cancel next month’s vaccine advisory committee meeting is raising concerns about whether the U.S. will have enough of the vaccine for the next flu season.
The FDA’s abrupt decision to cancel next month’s vaccine advisory committee meeting is raising concerns about whether the U.S. will have enough of the vaccine for the next flu season.
What's Your Reaction?
